Impact of cardiovascular rehabilitation and in TAVI (transcatheter aortic valve implantation) patients. Comparison with the impact of telerehabilitation as an alternative method in TAVI in Covid-19 era
- Conditions
- Cardiovascular rehabilitation in patients after TAVICirculatory System
- Registration Number
- ISRCTN32148715
- Lead Sponsor
- niversity of West Attica
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 75
1. Men and women aged 60-85 years
2. Will have undergone TAVI within a period of time 6 months before starting the cardiovascular rehabilitation program
3. Functional class of heart failure I to III, according to the functional classification of the New York Heart Association (NYHA)
4. Patients will be under medication and should have an ejection fraction (EF) =40%
5. Willing to be assigned to the study
1. Patients with severe-grade coronary artery disease
2. Genetic and non-genetic diseases that cause systolic or diastolic dysfunction
3. History of thromboembolic and vascular events diseases
4. Patients with an individual history of syncope fainting episodes and dangerous arrhythmias
5. Autoimmune patients or endocrinological diseases
6. Respiratory ailments
7. Neoplastic, hepatic, nephrological and infectious disease
8. Patients with disorders affecting the ability to exercise
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Measured at the initial visit and at the end of the study protocol:<br> 1. Functional capacity will be measured using ergospirometric indicators as peak oxygen uptake (VO2peak), respiratory equivalent slope for carbon dioxide (VE/VCO2)<br> 2. Survival rate will be assessed with the heart rate recovery index (HRR)<br> 3. The effects of cardiac symptoms will be assessed with the SF-36 quality of life scale<br>
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures